BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19023115)

  • 21. Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles.
    Cerino A; Meola A; Segagni L; Furione M; Marciano S; Triyatni M; Liang TJ; Nicosia A; Mondelli MU
    J Immunol; 2001 Oct; 167(7):3878-86. PubMed ID: 11564805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia.
    Nardi M; Tomlinson S; Greco MA; Karpatkin S
    Cell; 2001 Sep; 106(5):551-61. PubMed ID: 11551503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic platelet transfusions prevent murine T-cell-mediated immune thrombocytopenia.
    Guo L; Yang L; Speck ER; Aslam R; Kim M; McKenzie CG; Lazarus AH; Ni H; Hou M; Freedman J; Semple JW
    Blood; 2014 Jan; 123(3):422-7. PubMed ID: 24258817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
    Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
    Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.
    Shawky H; Maghraby AS; Solliman Mel-D; El-Mokadem MT; Sherif MM; Arafa A; Bahgat MM
    Arch Virol; 2015 Apr; 160(4):945-58. PubMed ID: 25631616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-associated IgM elevated in patients with chronic hepatitis C contains no anti-platelet autoantibodies.
    Kosugi S; Imai Y; Kurata Y; Tomiyama Y; Shiraga M; Honda S; Nishikawa M; Yonezawa T; Kanakura Y; Matsuzawa Y
    Liver; 1997 Oct; 17(5):230-7. PubMed ID: 9387914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein.
    Machida K; Kondo Y; Huang JY; Chen YC; Cheng KT; Keck Z; Foung S; Dubuisson J; Sung VM; Lai MM
    J Virol; 2008 Jul; 82(13):6711-20. PubMed ID: 18417597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients.
    Prezzi C; Nuzzo M; Meola A; Delmastro P; Galfrè G; Cortese R; Nicosia A; Monaci P
    J Immunol; 1996 Jun; 156(11):4504-13. PubMed ID: 8666827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a potential treatment to prevent HCV reinfection in liver transplant patients.
    Eren R; Landstein D; Terkieltaub D; Nussbaum O; Zauberman A; Ben-Porath J; Gopher J; Buchnick R; Kovjazin R; Rosenthal-Galili Z; Aviel S; Ilan E; Shoshany Y; Neville L; Waisman T; Ben-Moshe O; Kischitsky A; Foung SK; Keck ZY; Pappo O; Eid A; Jurim O; Zamir G; Galun E; Dagan S
    J Virol; 2006 Mar; 80(6):2654-64. PubMed ID: 16501075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine.
    Beaumont E; Patient R; Hourioux C; Dimier-Poisson I; Roingeard P
    Hepatology; 2013 Apr; 57(4):1303-13. PubMed ID: 23150224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
    Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
    Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping of a conformational epitope shared between E1 and E2 on the serum-derived human hepatitis C virus envelope.
    Petit MA; Jolivet-Reynaud C; Peronnet E; Michal Y; Trépo C
    J Biol Chem; 2003 Nov; 278(45):44385-92. PubMed ID: 12882983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus.
    Ray R; Khanna A; Lagging LM; Meyer K; Choo QL; Ralston R; Houghton M; Becherer PR
    J Virol; 1994 Jul; 68(7):4420-6. PubMed ID: 8207814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia.
    Aslam R; Kapur R; Segel GB; Guo L; Zufferey A; Ni H; Semple JW
    Exp Hematol; 2016 Oct; 44(10):924-930.e1. PubMed ID: 27417974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?
    Marceau G; Lapierre P; Béland K; Soudeyns H; Alvarez F
    Hepatology; 2005 Sep; 42(3):675-82. PubMed ID: 16037945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.
    Cao J; Chen Z; Ren Y; Luo Y; Cao M; Lu W; Zhao P; Qi Z
    Vaccine; 2011 May; 29(20):3714-23. PubMed ID: 21396407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombocytopenia associated with hepatitis C viral infection.
    Nagamine T; Ohtuka T; Takehara K; Arai T; Takagi H; Mori M
    J Hepatol; 1996 Feb; 24(2):135-40. PubMed ID: 8907565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The disulfide-rich region of platelet glycoprotein (GP) IIIa contains hydrophilic peptide sequences that bind anti-GPIIIa autoantibodies from patients with immune thrombocytopenic purpura (ITP).
    Beardsley DJ; Tang C; Chen BG; Lamborn C; Gomes E; Srimatkandada V
    Biophys Chem; 2003 Sep; 105(2-3):503-15. PubMed ID: 14499914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.